AVEO Pharmaceuticals, Inc. Debt to Equity Ratio 2010-2022 | AVEO
Current and historical debt to equity ratio values for AVEO Pharmaceuticals, Inc. (AVEO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AVEO Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-09-30 | $0.07B | $0.03B | 2.51 |
| 2022-06-30 | $0.07B | $0.03B | 2.21 |
| 2022-03-31 | $0.06B | $0.04B | 1.66 |
| 2021-12-31 | $0.06B | $0.05B | 1.30 |
| 2021-09-30 | $0.06B | $0.05B | 1.13 |
| 2021-06-30 | $0.05B | $0.06B | 0.88 |
| 2021-03-31 | $0.06B | $0.07B | 0.76 |
| 2020-12-31 | $0.03B | $0.04B | 0.90 |
| 2020-09-30 | $0.03B | $0.04B | 0.82 |
| 2020-06-30 | $0.03B | $0.05B | 0.57 |
| 2020-03-31 | $0.03B | $0.01B | 4.50 |
| 2019-12-31 | $0.04B | $0.02B | 2.41 |
| 2019-09-30 | $0.04B | $0.02B | 2.19 |
| 2019-06-30 | $0.04B | $0.00B | 24.51 |
| 2019-03-31 | $0.05B | $-0.02B | -2.43 |
| 2018-12-31 | $0.06B | $-0.03B | -2.03 |
| 2018-09-30 | $0.08B | $-0.06B | -1.36 |
| 2018-06-30 | $0.07B | $-0.05B | -1.44 |
| 2018-03-31 | $0.09B | $-0.05B | -1.87 |
| 2017-12-31 | $0.09B | $-0.04B | -2.23 |
| 2017-09-30 | $0.09B | $-0.05B | -1.94 |
| 2017-06-30 | $0.06B | $-0.02B | -3.20 |
| 2017-03-31 | $0.03B | $0.01B | 6.45 |
| 2016-12-31 | $0.03B | $-0.00B | -15.19 |
| 2016-09-30 | $0.03B | $0.00B | 8.93 |
| 2016-06-30 | $0.03B | $0.01B | 4.15 |
| 2016-03-31 | $0.02B | $0.01B | 2.11 |
| 2015-12-31 | $0.02B | $0.02B | 1.35 |
| 2015-09-30 | $0.02B | $0.02B | 0.84 |
| 2015-06-30 | $0.02B | $0.01B | 2.00 |
| 2015-03-31 | $0.04B | $0.02B | 2.43 |
| 2014-12-31 | $0.05B | $0.02B | 2.43 |
| 2014-09-30 | $0.05B | $0.03B | 1.52 |
| 2014-06-30 | $0.06B | $0.05B | 1.22 |
| 2014-03-31 | $0.06B | $0.06B | 0.99 |
| 2013-12-31 | $0.08B | $0.07B | 1.09 |
| 2013-09-30 | $0.08B | $0.09B | 0.90 |
| 2013-06-30 | $0.08B | $0.11B | 0.75 |
| 2013-03-31 | $0.09B | $0.14B | 0.61 |
| 2012-12-31 | $0.09B | $0.12B | 0.74 |
| 2012-09-30 | $0.08B | $0.14B | 0.58 |
| 2012-06-30 | $0.08B | $0.17B | 0.45 |
| 2012-03-31 | $0.07B | $0.19B | 0.37 |
| 2011-12-31 | $0.07B | $0.22B | 0.32 |
| 2011-09-30 | $0.07B | $0.25B | 0.29 |
| 2011-06-30 | $0.07B | $0.27B | 0.27 |
| 2011-03-31 | $0.10B | $0.16B | 0.64 |
| 2010-12-31 | $0.08B | $0.07B | 1.11 |
| 2010-09-30 | $0.07B | $0.02B | 3.12 |
| 2010-06-30 | $0.08B | $0.04B | 1.90 |
| 2010-03-31 | $0.07B | $0.05B | 1.46 |
| 2009-12-31 | $0.23B | $-0.17B | -1.35 |
| 2009-09-30 | $0.00B | 0.00 | |
| 2009-06-30 | $0.00B | 0.00 | |
| 2009-03-31 | $0.00B | 0.00 | |
